181 related articles for article (PubMed ID: 28562352)
1. Rapalogs can promote cancer cell stemness in vitro in a Galectin-1 and H-ras-dependent manner.
Posada IMD; Lectez B; Sharma M; Oetken-Lindholm C; Yetukuri L; Zhou Y; Aittokallio T; Abankwa D
Oncotarget; 2017 Jul; 8(27):44550-44566. PubMed ID: 28562352
[TBL] [Abstract][Full Text] [Related]
2. ASPP2 Is a Novel Pan-Ras Nanocluster Scaffold.
Posada IM; Serulla M; Zhou Y; Oetken-Lindholm C; Abankwa D; Lectez B
PLoS One; 2016; 11(7):e0159677. PubMed ID: 27437940
[TBL] [Abstract][Full Text] [Related]
3. Galectin-1 dimers can scaffold Raf-effectors to increase H-ras nanoclustering.
Blaževitš O; Mideksa YG; Šolman M; Ligabue A; Ariotti N; Nakhaeizadeh H; Fansa EK; Papageorgiou AC; Wittinghofer A; Ahmadian MR; Abankwa D
Sci Rep; 2016 Apr; 6():24165. PubMed ID: 27087647
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic Screening Identifies Protein Synthesis Inhibitors as H-Ras-Nanocluster-Increasing Tumor Growth Inducers.
Najumudeen AK; Posada IM; Lectez B; Zhou Y; Landor SK; Fallarero A; Vuorela P; Hancock J; Abankwa D
Biochemistry; 2015 Dec; 54(49):7212-21. PubMed ID: 26568031
[TBL] [Abstract][Full Text] [Related]
5. Galectin-1 is a novel structural component and a major regulator of h-ras nanoclusters.
Belanis L; Plowman SJ; Rotblat B; Hancock JF; Kloog Y
Mol Biol Cell; 2008 Apr; 19(4):1404-14. PubMed ID: 18234837
[TBL] [Abstract][Full Text] [Related]
6. Galectin-1 inhibition induces cell apoptosis through dual suppression of CXCR4 and Ras pathways in human malignant peripheral nerve sheath tumors.
Shih TC; Fan Y; Kiss S; Li X; Deng XN; Liu R; Chen XJ; Carney R; Chen A; Ghosh PM; Lam KS
Neuro Oncol; 2019 Nov; 21(11):1389-1400. PubMed ID: 31127849
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of Raf kinase recruitment to the GTPase H-ras depends on H-ras membrane conformer-specific nanoclustering.
Guzmán C; Šolman M; Ligabue A; Blaževitš O; Andrade DM; Reymond L; Eggeling C; Abankwa D
J Biol Chem; 2014 Apr; 289(14):9519-33. PubMed ID: 24569991
[TBL] [Abstract][Full Text] [Related]
8. H-Ras nanocluster stability regulates the magnitude of MAPK signal output.
Rotblat B; Belanis L; Liang H; Haklai R; Elad-Zefadia G; Hancock JF; Kloog Y; Plowman SJ
PLoS One; 2010 Aug; 5(8):e11991. PubMed ID: 20700538
[TBL] [Abstract][Full Text] [Related]
9. Galectin-3 promotes CXCR2 to augment the stem-like property of renal cell carcinoma.
Huang CS; Tang SJ; Lee MH; Chang Wang CC; Sun GH; Sun KH
J Cell Mol Med; 2018 Dec; 22(12):5909-5918. PubMed ID: 30246456
[TBL] [Abstract][Full Text] [Related]
10. Galectin-3 promotes chronic activation of K-Ras and differentiation block in malignant thyroid carcinomas.
Levy R; Grafi-Cohen M; Kraiem Z; Kloog Y
Mol Cancer Ther; 2010 Aug; 9(8):2208-19. PubMed ID: 20682656
[TBL] [Abstract][Full Text] [Related]
11. K-ras nanoclustering is subverted by overexpression of the scaffold protein galectin-3.
Shalom-Feuerstein R; Plowman SJ; Rotblat B; Ariotti N; Tian T; Hancock JF; Kloog Y
Cancer Res; 2008 Aug; 68(16):6608-16. PubMed ID: 18701484
[TBL] [Abstract][Full Text] [Related]
12. Specific cancer-associated mutations in the switch III region of Ras increase tumorigenicity by nanocluster augmentation.
Šolman M; Ligabue A; Blaževitš O; Jaiswal A; Zhou Y; Liang H; Lectez B; Kopra K; Guzmán C; Härmä H; Hancock JF; Aittokallio T; Abankwa D
Elife; 2015 Aug; 4():e08905. PubMed ID: 26274561
[TBL] [Abstract][Full Text] [Related]
13. Opposite feedback from mTORC1 to H-ras and K-ras4B downstream of SREBP1.
Posada IMD; Lectez B; Siddiqui FA; Oetken-Lindholm C; Sharma M; Abankwa D
Sci Rep; 2017 Aug; 7(1):8944. PubMed ID: 28827765
[TBL] [Abstract][Full Text] [Related]
14. SPRED1 Interferes with K-ras but Not H-ras Membrane Anchorage and Signaling.
Siljamäki E; Abankwa D
Mol Cell Biol; 2016 Oct; 36(20):2612-25. PubMed ID: 27503857
[TBL] [Abstract][Full Text] [Related]
15. Differential oncogenic Ras signaling and senescence in tumor cells.
Bihani T; Mason DX; Jackson TJ; Chen SC; Boettner B; Lin AW
Cell Cycle; 2004 Sep; 3(9):1201-7. PubMed ID: 15492501
[TBL] [Abstract][Full Text] [Related]
16. Let-7a regulates mammosphere formation capacity through Ras/NF-κB and Ras/MAPK/ERK pathway in breast cancer stem cells.
Xu C; Sun X; Qin S; Wang H; Zheng Z; Xu S; Luo G; Liu P; Liu J; Du N; Zhang Y; Liu D; Ren H
Cell Cycle; 2015; 14(11):1686-97. PubMed ID: 25955298
[TBL] [Abstract][Full Text] [Related]
17. ATP citrate lyase knockdown impacts cancer stem cells in vitro.
Hanai JI; Doro N; Seth P; Sukhatme VP
Cell Death Dis; 2013 Jun; 4(6):e696. PubMed ID: 23807225
[TBL] [Abstract][Full Text] [Related]
18. Overexpressed galectin-3 in pancreatic cancer induces cell proliferation and invasion by binding Ras and activating Ras signaling.
Song S; Ji B; Ramachandran V; Wang H; Hafley M; Logsdon C; Bresalier RS
PLoS One; 2012; 7(8):e42699. PubMed ID: 22900040
[TBL] [Abstract][Full Text] [Related]
19. Redox state influence on human galectin-1 function.
Yu X; Scott SA; Pritchard R; Houston TA; Ralph SJ; Blanchard H
Biochimie; 2015 Sep; 116():8-16. PubMed ID: 26116885
[TBL] [Abstract][Full Text] [Related]
20. Galectin-3 regulates a molecular switch from N-Ras to K-Ras usage in human breast carcinoma cells.
Shalom-Feuerstein R; Cooks T; Raz A; Kloog Y
Cancer Res; 2005 Aug; 65(16):7292-300. PubMed ID: 16103080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
